A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques

Last updated: August 7, 2023
Sponsor: Andreas Syggros Hospital of Venereal and Dermatological Diseases
Overall Status: Active - Recruiting

Phase

N/A

Condition

Rosacea

Contact Dermatitis

Allergy (Pediatric)

Treatment

patch test for diagnosing allergic contact dermatitis

Clinical Study ID

NCT05991674
131/2023
  • Ages > 18
  • All Genders

Study Summary

The goal of this study is to look into the patterns of sensitization to figure out how allergic contact dermatitis (ACD), individual susceptibility, and patient characteristics are connected. The joint application of classic statistics and machine learning methods will reveal the relationship between contact dermatitis expressions and several clinical characteristics.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Eligible patients were adults diagnosed with dermatitis who had a positive patch testresult on the chemical panel of Baseline Series of Allergens.

Exclusion

Exclusion Criteria:

  • Although there is no consensus for the definitive exclusion criteria from a patch testing,most studies agree that the chronic use of anti-inflammatory treatments, corticosteroids,and cyclosporine, high UV exposure and other chronic dermatoses are factors that mightproduce false- positive or false- negative results and thus should be avoided.

Study Design

Total Participants: 80
Treatment Group(s): 1
Primary Treatment: patch test for diagnosing allergic contact dermatitis
Phase:
Study Start date:
June 30, 2023
Estimated Completion Date:
October 30, 2023

Connect with a study center

  • Georgia Gogkla

    Athens, Attica 11621
    Greece

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.